Hyaluronic Acid Market Summary
As per Market Research Future Analysis, the Hyaluronic Acid Market was valued at USD 0.77 billion in 2024 and is projected to grow to USD 3.15 billion by 2035, with a CAGR of 13.72% from 2025 to 2035. The market is driven by increasing awareness of hyaluronic acid across various industries, including pharmaceuticals, cosmetics, and food. Its applications in joint health, skincare, and dietary supplements are expanding, with significant demand for both cosmetic and food-grade segments. The Asia-Pacific region leads the market, supported by strong manufacturing capabilities and a growing consumer base for cosmetic procedures.
Key Market Trends & Highlights
The Hyaluronic Acid Market is witnessing significant growth driven by diverse applications and increasing consumer awareness.
- Market Size in 2024: USD 0.77 Billion; projected to reach USD 3.15 Billion by 2035.
- CAGR during 2025-2035: 13.72%; fastest growing segment: food grade.
- Cosmetic grade segment held the largest market share in 2024; solid form is the fastest growing.
- Asia-Pacific accounted for the largest market share in 2024, driven by strong manufacturing and demand for cosmetic procedures.
Market Size & Forecast
2024 Market Size | USD 0.77 Billion |
2035 Market Size | USD 3.15 Billion |
CAGR (2025-2035) | 13.72% |
Major Players
Shandong Focusfreda Biotech Co., Ltd. (China), Wellona Pharma (India), Bloomage Biotech Co. Ltd. (China), Altergon Italia Srl (Italy), Stanford Chemicals (US), Titan Biotech Ltd. (India), Qufu Focuschem Trading Co. (China), Kewpie Corporation (Japan), Contipro A.S. (Czech Republic), Fufeng Group (China)